Louisiana Health Center COVID-19 Survey Summary Report

Latest data from September 24, 2021

Number of Health Center respondents = 23 (64% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 4,524
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 73.36%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 274
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 64.18%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 25.91% 35.04%
White, Hispanic/Latino Patients 6.30% 9.12%
Black/African American, Non-Hispanic/Latino Patients 60.65% 48.54%
Black/African American, Hispanic/Latino Patients 0.38% 0.00%
Asian Patients3 1.28% 1.46%
American Indian/Alaska Native Patients3 0.42% 1.09%
Native Hawaiian/Other Pacific Islander Patients3 0.13% 0.00%
Patients with More than one race3 0.24% 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.95% 2.55%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.57% 0.36%
Unreported/Refused to Report Race and Ethnicity 2.17% 1.82%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 987
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 82.26%
COVID-19 Immunization Series Completed 1,555
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 84.66%
COVID-19 Immunization Series Additional 399
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 79.29%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 14.29% 14.60% 17.54%
White, Hispanic/Latino Patients 8.11% 14.53% 2.51%
Black/African American, Non-Hispanic/Latino Patients 47.42% 39.36% 32.83%
Black/African American, Hispanic/Latino Patients 2.03% 2.38% 0.50%
Asian Patients3 2.03% 1.03% 0.00%
American Indian/Alaska Native Patients3 0.20% 2.06% 30.58%
Native Hawaiian/Other Pacific Islander Patients3 0.10% 13.05% 0.00%
Patients with More than one race3 2.43% 3.67% 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 3.95% 4.50% 0.75%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.11% 1.16% 0.25%
Unreported/Refused to Report Race and Ethnicity 18.34% 3.67% 15.04%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 26.09%
1 to 24 Hours 30.43%
More Than 24 Hours 39.13%
N/A 4.35%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 4.35%
Staffing to administer the vaccine 60.87%
Vaccine confidence 26.09%
Vaccine storage capacity 4.35%
Vaccine supply 13.04%
Other 26.09%
None 21.74%

Operations and Staff

Metrics Value
Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits 82.39%
Average Percent of Health Center Visits Conducted Virtually 22.39%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 43.48%
Number of Mobile Van Sites 7
Number of Pop-up Clinics 22
Number of School-Based Vaccination Sites 7

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 8.70%
Refer patients to another organization that provides monoclonal antibody therapies 47.83%
None 47.83%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 4.35%
Patient awareness/education 13.04%
Staffing capacity 39.13%
Therapy administration/onsite logistics 34.78%
Other 8.70%
None 52.17%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021